The cytokine response to streptococcal superantigens varies between individual toxins and between individuals: Implications for the pathogenesis of group a streptococcal diseases

Journal of Interferon and Cytokine Research

Volumn 27, Issue 7, 2007, Pages 553-557

  Proft, Thomas ^a   Schrage, Birgit ^a,b   Fraser, John D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CYTOKINE; STREPTOCOCCUS ANTIGEN; SUPERANTIGEN;

ARTICLE; AUTOIMMUNE DISEASE; BLOOD DONOR; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DEVICE; HUMAN; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TH1 CELL; TH2 CELL;

CELLS, CULTURED; CYTOKINES; HUMANS; RECOMBINANT PROTEINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; SUPERANTIGENS; TH1 CELLS; TH2 CELLS;

EID: 34547181770     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.0173     Document Type: Article

References (20)

1. Cunningham M. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 2000;13:470-511.
2. Stevens DL. Invasive group A streptococcus infections. Clin. Infect. Dis. 1992;14:2-13.
3. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 2001;55:77-104.
4. Proft T, Schrage B, Fraser J. Superantigens - microbial toxins that target the immune system. In: Proft T, ed. Microbial Toxins - Molecular and Cellular Biology. Wymondham: Horizon Bioscience, 2005:179-214.
5. Sriskandan S, Moyes D, Cohen J. Detection of circulating bacterial superantigen and lymphotoxin-α in patients with streptococcal toxic shock syndrome. Lancet 1996;348:1315-1316.
6. Bonventre P, Heeg H, Cullen C, Lian CJ. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect. Immun. 1993;61:793-739.
7. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 1992;175:91-98.
8. Stevens D, Bryant A, Hackett S, Chang A, Peer G, Kosanke S, Emerson T, Hinshaw L. Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. J. Infect. Dis. 1996;173:619-626.
9. Beres SB, Sylva GL, Barbian KD, Lei B, Hoff JS, Mammarella ND, Liu MY, Smoot JC, Porcella SF, Parkins LD, Campbell DS, Smith TM, McCormick JK, Leung DY, Schlievert PM, Musser JM. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Natl. Acad. Sci. USA 2002;99: 10078-10083.
10. Ikebe T, Wada A, Inagaki Y, Sugama K, Suzuki R, Tanaka D, Tamaru A, Fujinaga Y, Abe Y, Shimizu Y, Watanabe H. Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive Streptococcus pyogenes M3/T3 isolates in Japan. Infect, lmmun. 2002;70:3227-3233.
11. Proft T, Webb PD, Handley V, Fraser JD. Two novel superantigens found in both group A and group C Streptococcus. Infect. Immun. 2003;71:1361-1369.
12. Smoot JC, Barbian KD, Van Gompel JJ, Smoot LM, Chaussee MS, Sylva GL, Sturdevant DE, Ricklefs SM, Porcella SF, Parkins LD, Beres SB, Campbell DS, Smith TM, Zhang Q, Kapur V, Daly JA, Veasy LG, Musser JM. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl. Acad. Sci. USA 2002;99:4668-4673.
13. Proft T, Moffatt SL, Berkahn CJ, Fraser JD. Identification and characterization of novel superantigens from Streptococcus pyogenes. J. Exp. Med. 1999;189:89-101.
14. Proft T, Sriskandan S, Yang L, Fraser JD. Superantigens and streptococcal toxic shock syndrome. Emerg. Infect. Dis. 2003;9: 1211-1218.
15. Yang L, Thomas M, Woodhouse A, Martin D, Fraser J, Proft T. Involvement of streptococcal mitogenic exotoxin Z in streptococcal toxic shock syndrome. J. Clin. Microbiol. 2005;43:3 570-3573.
16. Mueller-Alouf H, Alouf JE, Gerlach D, Ozegowski JH, Fitting C, Cavaillon JM. Human pro- and anti-inflammatory cytokine patterns induced by Streptococcus pyogenes erythrogenic (pyrogenic) exotoxins A and C superantigens. Infect. Immun. 1996;64: 1450-1453.
17. Rink L, Luhm J, Koester M, Kirchner H. Induction of a cytokine network by superantigens with parallel Th1 and Th2 stimulation. J. Interferon Cytokine Res. 1996;16:41-47.
18. Heaton T, Mallon D, Venaille T , Holt P. Staphylococcal enterotoxin induced IL-5 stimulation as a cofactor in the pathogenesis of atopic disease: the hygiene hypothesis in reverse? Allergy 2003; 58:252-256.
19. Llewelyn M, Sriskandan S, Peakman M, Ambrozak DR, Douek DC, Kwok WW, Cohen S, Altman DM. HLA class II polymorphisms determine responses to bacterial superantigens. J. Immunol. 2004;172;1719-1726.
20. Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Kurshid A, Green K, Peeples J, Wade J, Thomson G, Schwartz B, Low DE. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat. Med. 2002;8:1398-1404.